Purchase Order 36C24925P0040
Award Date
10/1/24
Potential Completion Date
9/30/26
Potential Value
$536K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Cytopath Biopsy Lab Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Memphis, TN 38104, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide testing of thyroid nodules for cancer using non-surgical testing procedures. The $36,000.00 contract has a completion date of June 30, 2022 and was awarded on a non-competitive basis without a set-aside. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services,...
This is a federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for $78,750.00 to provide ThyroSeq genomic testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type, awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6. The contract is for the ultimate completion date of September 30, 2026. Cytopath Biopsy Lab Inc. is a for-profit organization...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 awarded a firm-fixed-price purchase order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular testing services. The $2,250,000.00 contract has a period of performance from October 13, 2023 to October 12, 2025. Cytopath Biopsy Lab Inc. is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with expertise in cancer screening and...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), which is part of the U.S. Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract is for the provision of cytopathology and ThyroSeq genomic testing services, with a ceiling value of $8,000. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in cancer screening and diagnostic laboratory services, particularly for...
This federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, is for $64,400.00 to provide CYTOPATHOLOGY & THYROSEQUENCE TESTING SERVICES. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 30, 2026. The funding agency is the Veterans Integrated Service Network 2, a civilian agency under the U.S. Department of Veterans Affairs. The contract does not have a set-aside designation. Cblpath is a for-profit...
This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of specialized thyroid cancer diagnostic testing services to the U.S. Department of Veterans Affairs (VA). The contract, valued at $10,000.00, is a Blanket Purchase Agreement (BPA) call order issued under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. Cytopath Biopsy Lab Inc. will deliver its ThyroSeq molecular diagnostic testing services to support cancer...
This is a $300,000.00 firm fixed price contract awarded by the U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 1 to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide thyroid testing laboratory services. The contract is a Blanket Purchase Agreement (BPA) with a period of performance through September 29, 2026. Cytopath Biopsy Lab Inc. is an experienced provider of specialized thyroid cancer diagnostic testing services, including its ThyroSeq brand,...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $428,000.00 to provide THYROSEC TESTING services. The contract supports the VA's cancer screening and diagnosis programs, with Cytopath Biopsy Lab providing specialized thyroid cancer diagnostic testing using its ThyroSeq molecular diagnostic platform. This includes genetic mutation analysis to evaluate malignancy of thyroid nodules detected in...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a civilian agency within the Department of Veterans Affairs (VA), to Cytopath Biopsy Lab Inc. (operating as Cblpath), a for-profit organization. The $28,000.00 contract is for cytopathology and ThyroSeq genetic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The contract has an ultimate completion date of May 31, 2025...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, for the provision of ThyroSeq molecular diagnostic testing services. The $288,000.00 contract has an ultimate completion date of January 31, 2026 and will support cancer screening and diagnosis programs for veterans and active military personnel. Cytopath Biopsy Lab Inc. is a for-profit organization that specializes in anatomic...